Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

MedTech

Biocartis (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART) announces to have signed an agreement with Nichirei Bioscience, a supplier of biological and diagnostics products in Japan, for the product registration and exclusive distribution of Biocartis' molecular diagnostic (MDx) oncology tests in Japan, operating on the fully automated sample-to-result Idylla(TM) platform.

Read more ...

Underscores strong business and innovation momentum. 10x Genomics announced $35 million in funding as an extension of its Series D financing. The round was led by Meritech Capital with Fidelity and Wells Fargo participating. The company’s total financing to date is $243 million.announcement builds on 10x Genomics’ continued growth and commitment to advancing biology. In the last six months, 10x acquired two companies, Epinomics and Spatial Transcriptomics – players in the fields of epigenetics and spatial genomics – to develop products that provide invaluable insights for unlocking fundamental biology, understanding disease and advancing human health. The company has also added a research facility in Sweden to develop new technologies.

Read more ...

Frederick, MD Akonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, and intends to market advanced MDx systems, announced it has filed a 510(k) submission with the U.S. Food and Drug Administration (FDA) for approval of the TruDiagnosis® system, its proprietary, microarray-based technology. The TruDiagnosis system is an in vitro diagnostic device intended for genotyping multiple genes in a DNA sample utilizing on-slide polymerase chain reaction (PCR) gel-drop microarray technology. The system is comprised of the TruDx® 2000 Imager, TruSpotTM Software, and the TruArray® consumable test kit, all unique, patented technologies developed in-house at Akonni.

Read more ...

ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, CRISPR Therapeutics and Vertex Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for CTX001 for the treatment of sickle cell disease (SCD). CTX001 is an investigational, autologous, gene-edited hematopoietic stem cell therapy for patients suffering from severe hemoglobinopathies.

Read more ...

Initial product development to focus on chest pain assessment in the emergency department BOULDER, COLO. (PRWEB) Brava Diagnostics, a company developing point-of-care tests for acute care settings, announced an exclusive worldwide License Agreement and collaboration with MBio Diagnostics, a company a new era in rapid, multiplex testing. This partnership will focus initially on modifying MBio’s LightDeck® System to meet the needs of the in vitro diagnostics marketplace and developing a rapid assay for chest pain assessment in the emergency department.

Read more ...

Mobidiag, a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, announces the CE-IVD marking of Novodiag® CarbaR+. Novodiag® CarbaR+ is a single molecular test allowing fully automated detection of Carbapenemase-Producing Enterobacteriaceae (CPE), and associated resistance markers. CPE are bacteria that are resistant to carbapenem class of antibiotics. In addition, Novodiag®CarbaR+ identifies a plasmid-mediated resistance to colistin. Colistin is considered the drug of last resort for many infections.

Read more ...

Upcoming Events

No events

Presentation

Micromachined Ultrasound Technologies: An Overview of Emerging Trends and Applications
Discover the presentation held by Jérôme Mouly, Senior Technology & Market Analyst, Inkjet...
CRISPR Technology & Market Overview: challenges, market competition landscape and strategic opportunities
Discover the presentation held by Asma Siari, Technology & Market Analyst in Biotechnologies...
Birth of a Future Giant: Zoom on the Chinese Microfluidics Industry
Discover the presentation held by Sébastien Clerc, Market & Technology Analyst, Microfluidi...

Access to all our presentations